Company: PFSA
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0001213900-25-044417
Chunk: 77

Company: Profusa, Inc.
Filing Date: 2025-05-15
Form: 424B3
Chunk 77
---
 of the Merger Agreement. The Business Combination is not conditioned on the Governance Proposal, the Director Election Proposal, or the Adjournment Proposal. If the Business Combination Proposal is not approved, the other proposals (except the Adjournment Proposal) will not be presented to the stockholders for a vote. Recommendation to NorthView Holders The NorthView Board believes that the Business Combination Proposal and the other Proposals to be presented at the Special Meeting are fair to, and in the best interest of, NorthView’s stockholders and unanimously recommends that its stockholders vote “FOR” the Business Combination Proposal, “FOR” the Charter Proposal, “FOR” the Governance Proposals, “FOR” the Equity Incentive Plan Proposal, “FOR” the ESPP Proposal, “FOR” the Nasdaq Proposals, and “FOR” the Adjournment Proposal, if presented, as well as “FOR” the election of each of the nominees to the Board of Directors listed in this proxy statement/prospectus. When you consider the NorthView Board’s recommendation of the Proposals, you should keep in mind that the Sponsor and NorthView’s directors, officers and initial stockholders have interests in the Business Combination that are different from, or in addition to, the interests of NorthView stockholders generally. Please see the section entitled “ Proposal 1 — The Business Combination Proposal — Interests of Certain Persons in the Business Combination and Conflicts of Interest” for additional information. The NorthView Board was aware of and considered these interests, among other matters, in evaluating and negotiating the Transactions and in recommending to the NorthView stockholders that they vote “FOR” the proposals presented at the Special Meeting. 15 On December20, 2024, NorthView received a delisting determination letter from Nasdaq as the 36 -monthanniversary from its IPO has passed on December27, 2024, and NorthView’s securities were suspended from trading and delisted from Nasdaq. As of the same date, NorthView’s securities started being quoted on OTC Pink. There could be substantial risks to NorthView and New Profusa as a result of NorthView’s non -compliancewith this rule. See “ Risk Factors — Risks Related to NorthView and the Business Combination.” This could have significant material adverse consequences on NorthView and its securities, including that it will negatively impact its ability to complete a business combination, will limit investors’ ability to make transactions in its securities and could subject it to additional trading restrictions. There may be actual